Kulikova et al. described an approach to induce an anti-tumor immunity in mononuclear cell (MNC) cultures from CRC patients using DNA-transfected DCs encoding the TAA epitopes of CEA, mucin 4, and the epithelial cell adhesion molecule (74). The gene discussed is CEACAM5; the disease is neoplasm.